As of September 26, 2026, ElevenLabs has not filed a registration statement for an initial public offering; no Form S-1 appears for the company on SEC EDGAR, the U.S. Securities and Exchange Commission's public filing database, which covers only U.S. securities filings and would not reflect a listing filed with a non-U.S. regulator or exchange. Bloomberg reported via the Reuters wire on July 2, 2026 that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion, a liquidity event for existing shareholders that is separate from an IPO. More recently, when TechCrunch directly asked ElevenLabs CEO Mati Staniszewski on September 24, 2026 to confirm reports that the company is "looking at 2028 for an IPO," he did not deny it, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place." That is preparation, not a committed date, and no filing has followed the remark.
segmara.com publishes educational private-market context and can route limited interest into account-based private follow-up. Public pages do not create an offer, allocation, payment instruction, investment advice, or issuer-affiliated workflow.
Key points
A stock sale is not a listing
Bloomberg reported on July 2, 2026, via the Reuters wire, that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion. An employee stock sale lets current staff or early shareholders sell existing shares to investors; it moves money between private parties and does not create publicly tradable stock.
That kind of transaction is separate from an initial public offering. It requires no registration statement, no prospectus, and no review by a securities regulator, so its existence says nothing on its own about whether or when ElevenLabs intends to list on an exchange.
The CEO did not say no
On September 24, 2026, TechCrunch asked ElevenLabs CEO Mati Staniszewski directly to confirm reports that the company is 'looking at 2028 for an IPO.' He did not deny it, replying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
That is a statement about preparation, not a commitment. It names no filing date, no exchange, and no underwriter, and it explicitly conditions any IPO on future timing and circumstances that Staniszewski described as undetermined.
What a filing would look like, and what has not happened
A US initial public offering requires a Form S-1 registration statement filed with the SEC and published on SEC EDGAR, the agency's public filing database. As of September 26, 2026, no such filing exists for ElevenLabs on EDGAR. EDGAR covers only US securities filings, so it would not show a listing filed with a different national regulator or exchange either.
Until a filing appears, or ElevenLabs or a regulator states a specific date, any 'ElevenLabs IPO date' circulating online remains speculation. Track SEC EDGAR and ElevenLabs' own statements directly rather than secondary rumors.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
Metric
Value
Context
Canonical route
/blog/when-will-elevenlabs-ipo
Stable URL path for AI and search extraction.
Article title
When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target
Main page topic.
Attached public sources
2
Number of citation links rendered at the bottom of the article.
Segmara listed companies
51
Live private-company listings in the public catalogue.
Priced listings
37
Catalogue listings with visible indicative or direct marks.
Request-quote listings
14
Catalogue listings where a public price is intentionally not invented.
Data fingerprint chart
Catalogue breadth100%
51 public listings
Visible pricing coverage72%
37 of 51 listings show a mark
Source depth48%
2 source links
Stage
Timing
Price / valuation signal
Interpretation
Chart metric
Score
Interpretation
Catalogue breadth
100 / 100
51 public listings
Visible pricing coverage
72 / 100
37 of 51 listings show a mark
Source depth
48 / 100
2 source links
Analytical lens
Search intent
The search behind 'When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target' is an access-intent query. People want to know where they can start interest in ElevenLabs private-market exposure without needing a private equity relationship, fund connection, or insider network.
Access path
segmara.com turns that search into a simple path: browse the listing, create an account, choose the company, and start the private-share inquiry. Final pricing and availability still depend on the route, but the starting point is public and straightforward.
Segmara role
Segmara works as a private-market access layer for interested visitors. The site helps visitors discover private markets categories that were previously hard to research and moves them into an account-based inquiry in a few steps.
Private-share path map
From gatekept to accessible
BrowseRetail investor finds a private-company listing.
AccountBuyer creates one Segmara account.
RequestBuyer starts the private-share purchase request.
CloseAvailability, price, approvals, and final terms are handled privately.
Access-friction chart
Illustrative map of where the old private-market process was hardest and where Segmara makes the starting point easier.
Old-market frictionPrivate networks and institutional access
Segmara discoveryPublic listings retail buyers can browse
Account workflowOne account to start the purchase request
Private closeFinal terms handled after buyer interest
How private-share access starts on Segmara
No S-1 or F-1 appears for ElevenLabs on SEC EDGAR as of the latest site review. Bloomberg reported via the Reuters wire on July 2, 2026 that the company was exploring an employee stock sale at a valuation of roughly $22 billion, a private secondary transaction involving existing shares, not a public offering.
Asked directly by TechCrunch on September 24, 2026 to confirm reports that ElevenLabs is 'looking at 2028 for an IPO,' CEO Mati Staniszewski did not deny it, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
Staniszewski's answer describes preparation, not a scheduled listing date or a filing; taken with the roughly $22 billion valuation Bloomberg reported nearly three months earlier, it shows a company gaining scale while stopping short of confirming when, or whether, it will go public.
Risk notes
Rumor risk: unofficial dates, valuations, or funding details circulating on social media or forums are frequently wrong or outdated and should not be treated as confirmation of anything.
Illiquidity risk: any private-market interest, indicative marks, or pre-IPO share arrangements in a company that has not listed can be difficult to exit and may not reflect a tradable price.
Timing risk: a company can pause, restart, or abandon IPO preparation at any stage, including after a confidential or public filing, so no step before pricing guarantees a listing.
A weekly IPO Pipeline Brief plus same-day filing alerts on ElevenLabs and 80+ other private tech companies. $15 a month, cancel anytime. Research only, no share sales.
Can retail investors track private-company shares on Segmara?
Yes. Visitors can start with the free ElevenLabs tracker using email only, then decide whether a private follow-up makes sense. Availability, eligibility, pricing, allocation, transfer approval, documents, and final terms can still vary by route.
Why was this market historically hard for retail investors to reach?
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: visitors can follow named private-company interest before any account, document upload, or payment step.
What is the easiest next step?
Open the free ElevenLabs tracker first. It is email-only and keeps the public step narrow while final availability, pricing, eligibility, and terms are handled only through private follow-up.
Has ElevenLabs confirmed an IPO date?
No. As of the latest site review, no Form S-1 or other registration statement has been filed with the SEC or any other regulator. When TechCrunch asked CEO Mati Staniszewski directly on September 24, 2026 whether a reported 2028 target was accurate, he did not deny it but did not name a date either, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
What is ElevenLabs worth?
The most recent figure comes from Bloomberg, reported via the Reuters wire on July 2, 2026: ElevenLabs was said to be exploring an employee stock sale at a valuation of roughly $22 billion. That figure is tied to a specific transaction reportedly under discussion, not an audited or company-confirmed valuation.
Is an employee stock sale the same as an IPO?
No. An employee stock sale, often called a tender offer, lets current employees or early shareholders sell existing shares to investors in a private transaction. It does not involve a public listing, a stock exchange, or a registration statement filed with a securities regulator. The July 2026 report describes this kind of private sale, not a public offering.
Can I buy ElevenLabs shares before the IPO?
Not through a public exchange, since ElevenLabs has not filed to go public. Any private-share offer you encounter should be verified independently before you rely on it. Segmara does not sell, broker, or arrange purchases of ElevenLabs shares.
Next step
Track private-market prices free.
If this article helped explain ElevenLabs, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account, and no allocation promise.
When a full account makes sense, Segmara can route limited interest into an account-based private follow-up. Availability, pricing, eligibility, allocation, transfer approval, liquidity, and final terms can vary by company and route.